Muhammad Noor Nordin

Dr. Muhammad Noor Nordin

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2026 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MNMuhammad Noor Nordin
Muhammad Noor Nordin
NANur Farhana Shahrul Azhar
Nur Farhana Shahrul Azhar
NNNURHAKIMAH NORHASHIM
NURHAKIMAH NORHASHIM
INIli Farhana Mohamad Ali Nasri
Ili Farhana Mohamad Ali Nasri
NJNoor Hafidzah Jabarullah
Noor Hafidzah Jabarullah
Carbon quantum dots (CQDs) have attracted intense research interest due to their unique physicochemical properties and broad application potential. CQDs are a new class of ultrasmall fluorescent carbon nanoparticles (<10 nm) that exhibit bright photoluminescence, broad excitation spectra, high quantum yields (QYs), and excellent photostability. Structurally, they consist of graphitic sp2/sp3-hybridized carbon with amorphous or nanocrystalline cores. Unlike conventional semiconductor quantum dots (SQDs), which often contain toxic group II–VI, III–VI, or IV–VI elements, CQDs offer a safer and more environmentally friendly alternative for biomedical and cosmetic applications. This review summarizes recent advances in green-chemistry approaches for CQD synthesis, including top-down, bottom-up, waste-derived, and surface-functionalization methods. Particular attention is given to natural carbon sources, which provide low-cost, sustainable, and eco-friendly routes for scalable production. The optical, electronic, and toxicological properties of CQDs are discussed to clarify their performance and safety profiles. Special emphasis is placed on their emerging roles in wound healing and cosmetic formulations, which remain underexplored despite their promising potential. To our knowledge, this is the first comprehensive review focusing on the current progress, key challenges, and future perspectives of CQDs in beauty and personal care applications.

1 December 2021 in Herba Polonica
Verified
Journal Article
Open access
PDF file
AMAhmad Sabry Mohamad
Ahmad Sabry Mohamad
MNMuhammad Noor Nordin
Muhammad Noor Nordin
IAIsmail Che Ani
Ismail Che Ani
JJJohan Jemberang
Johan Jemberang
RIReezal Ishak
Reezal Ishak
RHRoszymah Hamzah
Roszymah Hamzah
Summary: Introduction: Volten VR4® capsules containing herb extract of Kaempferia parviflora has been claimed to reduce blood glucose in patients with diabetes. Objectives: This preliminary study is conducted to evaluate the efficacy of Volten VR4® on healthy individuals and type-2 diabetes mellitus volunteers. The extracts of 400 mg capsules of Kaempferia parviflora (KP) were used to measure the blood glucose level of 2-hour postprandial. Methods: The healthy group consists of 15 young adults aged 20-30 with no history of serious diseases, while the diabetic group includes 12 individuals aged 35-75 diagnosed with type-2 diabetes mellitus. Data were validated through the Willcoxon and Friedman test statistics and error distribution. The investigation was continued to trace the capsules contents of elements using inductively coupled plasma optical emission spectrometry (ICP-OES) techniques. Results: It has been shown that KP reducing blood sugar levels has been associated with flavonoids and methoxyflavones components. The result specifically showed that consuming VR4® capsules can significantly reduce blood glucose, either at the state of fasting or postprandially. In the study the content of mineral and heavy metal elements in VR4® capsules has been evaluated. Conclusion: Volten VR4® Kaempferia parviflora extract is safe to be consumed at a single dose of 400 mg. The study also has shown that the participants are free from adverse reactions and hypoglycaemia.